REDHILL BIOPHARMA LTD.

Codice
RDHL
Risorse esterne
Opinione della community
Prezzo Variazione Volume
8.77 +2.69 €
(+44.24%)
49051
P/E Obiettivo ad 1anno
0 28 €

Compra - Vendi

0
Tutte le tue transazioni per questo titolo

Devi effettuare l'accesso


Grafico

Altri utenti che hanno investito

Transations in last week
Buy: 24
Sell : 13

Freak Demi9996 boss66 Riky3695 AngerManagement Imperator Antonio Peluso Sipra Vlad Alexandru Cerbero

Commenti


Notizie

Harvard Bioscience, Inc. (HBIO) is at $2.95 per share and RedHill Biopharma Ltd. (RDHL) is listed at $8.54 - Stocks Gallery

In recent trading day Harvard Bioscience, Inc. (HBIO) stock showed the move of 1.72% with the closing price of $2.95. Closing price generally refers to the last price at which a stock trades during a regular trading session. The company moved in the ...altro » Leggi

RedHill Biopharma Ltd - ADR (RDHL) Reaches $9.05 After 5.00 ... - High Point Observer

The stock of RedHill Biopharma Ltd - ADR (NASDAQ:RDHL) is a huge mover today! About 58934 shares traded. RedHill Biopharma Ltd - ADR ... Leggi

Here's how analysts see RedHill Biopharma Ltd – ADR (NASDAQ ... - Finance News Daily

Among 7 analysts covering RedHill Biopharma (NASDAQ:RDHL), 7 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. RedHill Biopharma had 11 ... Leggi

Biotech Movers: Red Hill Jumps After Securing Rights Sell GERD Treatment - TheStreet.com

Shares of RedHill Biopharma Ltd. (RDHL) rose 3.63%, or 31 cents, to $8.85 in pre-market trading Thursday, Aug. 17 after the company announced a commercialization agreement with ParaPRO LLC giving RedHill exclusive rights to promote Esomeprazolealtro » Leggi

RedHill Biopharma Ltd. (RDHL) noted a price change of 0.47% and Cidara Therapeutics, Inc. (CDTX) closes with a ... - Stocks Gallery

In latest trading activity; RedHill Biopharma Ltd. (RDHL) snatched the consideration from Investors, when its current beneficial picture was seen that is promoting good health. The stock price is showing encouraging image with current supportive move ... Leggi

Coming of age, Israel biotech sector gets ready for market - The Times of Israel

Indeed, companies like BiondVax, a developer of a universal flu vaccine candidate; Gamida Cell, a maker of cell and immune therapy technologies; RedHill Biopharma Ltd, a developer of drugs for gastrointestinal diseases; and Vascular Biogenics Ltd. (VBL ... Leggi

Awesome Oscillator Trending Downward For Redhill Biopharma Ltd (RDHL) - Melville Review

Redhill Biopharma Ltd (RDHL) shares are being watched closely by traders as the Awesome Oscillator signal is revealing a downward trend building over the past five bars, signaling that market momentum is building for the name. The Awesome Oscillator ... Leggi

Bank of New York Mellon Corp Invests $101,000 in Redhill ... - Markets Daily

Bank of New York Mellon Corp acquired a new position in shares of Redhill Biopharma Ltd. (NASDAQ:RDHL) during the first quarter, according to its most ... Leggi

Bank Hapoalim Bm Boosted Redhill Biopharma LTD (RDHL) Stake; Makaira Partners Trimmed Credit Acceptance ... - MoneyMakingArticles

Redhill Biopharma Ltd now has $146.58 million valuation. The stock rose 0.23% or $0.02 reaching $8.6 per share. About 15,713 shares traded. RedHill Biopharma Ltd – ADR (NASDAQ:RDHL) has declined 9.09% since August 16, 2016 and is downtrending. Leggi

Roth Capital Reiterates “$27.00” Price Target for Redhill Biopharma ... - Markets Daily

Redhill Biopharma Ltd. (NASDAQ:RDHL) received a $27.00 price target from Roth Capital in a report issued on Monday, July 31st. The firm presently has a ... Leggi